Prevention of pegfilgrastim-induced bone pain (PIP): A URCC CCOP randomized, double-blind, placebo-controlled trial of 510 cancer patients.
Year: 2010
Type: conference-abstract
Source: Journal of Clinical Oncology
Authors: J. J. Kirshner, C. E. Heckler, S. R. Dakhil, J. O. Hopkins, C. Coles, G. R. Morrow
Language: English
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W2227251621
